ClinConnect ClinConnect Logo
Search / Trial NCT06530108

The Effect of Sexual Education Based on the PLISSIT Model on Sexual Function, Attitudes Towards Sexuality and Sexual Distress in Pregnant Women

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Jul 28, 2024

Trial Information

Current as of August 20, 2025

Enrolling by invitation

Keywords

Sexual Function Sexual Attitude Sexual Distress Midwife Care Education

ClinConnect Summary

The Effect of Sexual Education Based on the PLISSIT Model on Sexual Function, Attitudes towards Sexuality and Sexual Distress in Pregnant Women

Method of the study: FSFI will be applied to pregnant women between 14-20 weeks of gestation who apply to Trakya University Health Research and Application Center Obstetrics Clinic, Polyclinic and Perinatology Clinic departments, and women with a score ≤ 26.55 as a result of the FSFI evaluation will be defined as having sexual dysfunction. Pregnant women will be randomized according to the last digit of their protocol number. Pregnant women divided...

Gender

FEMALE

Eligibility criteria

  • inclusion criteria: Volunteer to participate, 19 years of age and over, sexually active, at least primary school graduate, of Turkish origin, no communication problems, 14th-20th age, fluent in Turkish. Pregnant women in their 2nd week will be included in the study.
  • exclusion criteria: Pregnant women who are at serious risk during pregnancy, who are diagnosed with sexual dysfunction, who have mental problems that require treatment, and who use drugs that cause sexual dysfunction will not be included in the study Pregnant women who leave their information forms unfinished, experience loss, and want to leave the study will be excluded.
  • -

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported